0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query qyresearch united states chronic kidney disease ckd drugs industry 2015 market research report.Your search for "" gave back 1533064 results.
Urinary collection device (UCD) is a medical product helps in managing urinary output, hygiene required for long term medical care and collection of...
Catalog:
LPI
March 2023
Price: USD 3,660.00
T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H1 2018 Summary According to the recently published report 'T Cell...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
Adenosine Receptor A3 - Drugs In Development, 2021 Summary Adenosine Receptor A3 (ADORA3) - The adenosine A3 receptor, also known as ADORA3, is an...
Catalog:
Global Markets Direct
July 2021
Price: USD 3,500.00
Cytochrome P450 11B2 Mitochondrial (Aldosterone Synthase or Cytochrome P450Aldo or Cytochrome P450C18 or Steroid 18 Hydroxylase or CYP11B2 or EC 1.14...
Catalog:
Global Markets Direct
October 2018
Price: USD 3,500.00
Gouty Arthritis (Gout) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct...
Catalog:
Global Markets Direct
October 2022
Price: USD 2,000.00
Chronic kidney disease (CKD) is a slow and progressive loss of kidney function over several years. Eventually, a person may develop kidney failure...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Summary Publisher estimates that the PEGylated Proteins market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog:
HYR
May 2021
Price: USD 2,000.00
Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Drugs in Development, 2021 Summary Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Soluble guanylyl...
Catalog:
Global Markets Direct
October 2021
Price: USD 3,500.00
Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary...
Catalog:
Global Markets Direct
October 2022
Price: USD 3,500.00
In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Intravenous Iron...
Catalog:
9Dimen Research
January 2020
Price: USD 2,850.00
Cytochrome P450 11B2 Mitochondrial - Pipeline Review, H2 2019 Summary Cytochrome P450 11B2 Mitochondrial (Aldosterone Synthase or Cytochrome P450Aldo...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
The global Kidney Fibrosis Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Kidney Fibrosis Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Kidney Fibrosis...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Kidney Fibrosis Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (...
Catalog:
GIR
February 2023
Price: USD 4,480.00
